Nachrichten zur Hims & Hers Health Aktie

Hims & Hers Health (HIMS) stock rises as the company inks a partnership to sell Eli Lillys (LLY) weight-loss drugs,…

Eli Lilly and Hims & Hers announced an agreement on November 6, 2026 to expand access to Zepbound and Foundayo…

Agreement gives patients a path to FDA-approved treatments at self-pay price through the Hims Hers platform Eli Lilly and…

Eli Lilly has signed an agreement with Hims & Hers that will see its weight-loss therapies sold directly on the…

Eli Lilly and Company (NYSE: LLY) and Hims & Hers Health, Inc. (NYSE: HIMS) announced an agreement to make two…

View on Westlaw or start a FREE TRIAL today, FE, Business Information & News…

By Michael ErmanEli Lilly NYSE:LLY said on Friday it struck a deal to allow telehealth company Hims & Hers Health…

Nov 6 (Reuters) - Eli Lilly said on Friday it struck a deal to allow telehealth company Hims & Hers…

Lilly partners with Hims & Hers to offer weight-loss drugs…

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Hims & Hers Health, Inc. (NYSE: HIMS) today announced an agreement…

Telehealth provider Hims & Hers Health (NYSE:HIMS) shares rose 5% to $25.32 during the Nov. 6 trading session. In a separate…

Agreement gives patients a path to FDA-approved treatments at self-pay price through the Hims & Hers platform Eli Lilly and…

In the most recent trading session, Hims & Hers Health, Inc. (HIMS) closed at $24.06, indicating a -9.75% shift from…

Nearly 12% off the $26.25 open to $23.12 takes roughly $600 million off a $5.2 billion company in one session.…

Hims & Hers Health slides 4.82% today to $25.37 after legal risks increase and sellers dominate the stock performance.…

Hims & Hers adds four partners to benefits program…

Hims & Hers adds four partners to benefits program…

Hims & Hers Health, Inc. (NYSE: HIMS), the leading health and wellness platform, today announced four new partners joining Hims…

Hims & Hers Health, Inc. (NYSE: HIMS) announced four new partners joining its Hims & Hers Benefits program: Grüns, Medjet,…

Hims & Hers Health trades at $26.66 today, up 3.57%. Get the latest on HIMS stock price action and technical…

What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in…

Hims & Hers Health surged 9.14% to close at $28.05 on Monday, gaining $2.35 alongside broader momentum across the digital…

Hims & Hers Health surges 9.67% today to $28.23, ahead of its Q3 2026 earnings, drawing renewed investor focus despite…

Hims & Hers Health trades at $25.7 today, gaining 1.84%. Track key levels and price action for the latest market…

Weight loss drugs, peptide bets and a global telehealth build out kept headlines busy, but the investment result was very…

Hims & Hers Health drops 8.85% today to $25.24, with selling pressure ahead of Q3 2026 earnings. Key technicals remain…

Hims & Hers slides 3.27% today to $26.79 amid earnings anticipation and lawsuits, as selling pressure weighs on the price.…

LOS ANGELES, Nov. 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Hims & Hers…

LOS ANGELES, Nov. 02, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm notifies investors in Hims & Hers Health, Inc.…

For questions about this article or underlying research, email help@trefis.com. Hims & Hers Health (HIMS) stock fell 10.5% between its…

Investors in Hims & Hers Health, Inc., Unicycive Therapeutics, Inc., and Papa Johns International, Inc. have upcoming deadlines to seek…

Investors in Hims & Hers Health, Inc., Unicycive Therapeutics, Inc., and Papa Johns International, Inc. have upcoming…

Explore federal lobbying disclosures, spending trends, issues, agencies, bills, hired firms, lobbyists, and report images for Hims & Hers Health…

NEW YORK, NY - October 29, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has…